Methodological Evaluation of Renal Time-integrated Activity Coefficient Calculated using Trapezoidal Method and Non-linear Mixed-Effects Modeling in [177Lu]Lu-DOTA-TATE Therapy
Abstract
Keywords
Full Text:
PDFReferences
M. Kalantarhormozi, S. Hassanzadeh, S. J. Rekabpour et al., World J. Nucl. Med. 21 (2022) 215.
J. Hofland, T. Brabander, F. A. Verburg et al., J. Clin. Endocrinol. Metab. 107 (2022) 3199.
P. Kletting, T. Kull, C. Maaß et al., J. Nucl. Med. 57 (2016) 503.
N. R. Hidayati, A. Poon , K. Willowson et al., Atom Indones. 45 (2019) 147.
J. A. Siegel, S. R. Thomas, J. B. Stubbs et al., J. Nucl. Med. 40 (1999) 37S.
G. Glatting, Time-Activity Curves: Data, Models, Curve Fitting, and Model Selection, in: Handbook of Nuclear Medicine and Molecular Imaging for Physicists, CRC Press, (2022) 13.
S. M. B. Peters, M. C. T. Mink, B. M. Privé et al., EJNMMI Res. 13 (2023) 6.
D. Hardiansyah, A. Riana, A. J. Beer et al., Z. Med. Phys. 33 (2023) 70.
I. Budiansah, D. Hardiansyah, A. Riana et al., EJNMMI Phys. 12 (2025) 26.
O. V. Ivashchenko, J. O’Doherty, D. Hardiansyah et al., Med. Phys. 52 (2025) e70043.
M. G. Stabin, Fundamentals of Nuclear Medicine Dosimetry, Springer, New York (2008).
M. Lassmann, C. Chiesa, G. Flux et al., Eur. J. Nucl. Med. Mol. Imaging 38 (2011) 192.
G. Glatting, M. Bardiès, and M. Lassmann, Z. Med. Phys. 23 (2013) 262.
D. Hardiansyah, C. Maass, A. A. Attarwala et al., Eur. J. Nucl. Med. Mol. Imaging 43 (2016) 871.
D. Hardiansyah, E. Yousefzadeh-Nowshahr, F. Kind et al., J. Nucl. Med. 65 (2024) 566.
T. P. Devasia, Y. K. Dewaraja, K. A. Frey et al., J. Nucl. Med. 62 (2021) 1118.
D. Hardiansyah, A. Riana, M. Eiber et al., Z. Med. Phys. 34 (2024) 419.
P. L. Bonate, Pharmacokinetic-Pharmacodynamic Modeling and Simulation, Springer US, Boston (2011) 233.
D. Mould and R. Upton, CPT Pharmacometrics Syst. Pharmacol. 1 (2012) e6.
D. Hardiansyah, A. Riana, H. Hänscheid et al., EJNMMI Phys. 12 (2025) 37.
R Core Team, R: A Language and Environment for Statistical Computing, R Foundation for Statistical Computing, Vienna (2025), https://www.r-project.org/
D. R. Mould and R. N. Upton, CPT Pharmacometrics Syst. Pharmacol. 2 (2013) e38.
J. S. Owen and J. Fiedler-Kelly, Introduction to Population Pharmacokinetic/Pharmacodynamic Analysis with Nonlinear Mixed Effects Models, John Wiley & Sons, Hoboken, New Jersey (2014) 9.
R. J. Bauer, NONMEM Users Guide: Introduction to NONMEM 7.6.0, ICON plc, Blue Bell (2024).
R. J. Bauer, CPT Pharmacometrics Syst. Pharmacol. 8 (2019) 525.
R. J. Bauer, Pharmacometrics Syst. Pharmacol. 8 (2019) 538.
P. Kletting, S. Schimmel, H. A. Kestler et al., Med. Phys. 40 (2013) 102504.
P. Kletting, S. Schimmel, H. Hänscheid et al., Z. Med. Phys. 25 (2015) 264.
O. V. Ivashchenko, J. O’Doherty, D. Hardiansyah et al., Phys. Med. 117 (2024) 103192.
S. E. Strand, P. Zanzonico, and T. K. Johnson, Med. Phys. 20 (1993) 515.
G. Glatting, P. Kletting, S. N. Reske et al., Med. Phys. 34 (2007) 4285.
P. Kletting and G. Glatting, Z. Med. Phys. 19 (2009) 200.
DOI: https://doi.org/10.55981/aij.2026.1881
Copyright (c) 2026 Atom Indonesia

This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.









